Profiel
Rizwana F.
Sproule worked as an Executive Director at Amgen, Inc. from 2008 to 2014 and as a Vice President-Regulatory Affairs at Kite Pharma, Inc. from 2014 to 2018.
She received her undergraduate and doctorate degrees from the University of Warwick.
Eerdere bekende functies van Rizwana F. Sproule
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Director/Board Member | - |
| KITE PHARMA INC | General Counsel | - |
Opleiding van Rizwana F. Sproule
| University of Warwick | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
